New York, New York, United States Zola appeared to be the Corporate Investor, which was created in 2013. The leading representative office of defined Corporate Investor is situated in the New York. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Zola, startups are often financed by Rahul Mehta, Nimble Ventures, LIAN Group. The meaningful sponsors for the fund in investment in the same round are Olive Tree Capital, Jackson Square Ventures, Greenoaks Capital. In the next rounds fund is usually obtained by DNA Capital.
The high activity for fund was in 2018. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 50 - 100 millions dollars.
This organization was formed by Felix Lung, Kevin Ryan, Nobu Nakaguchi, Shan-Lyn Ma.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Alto Pharmacy Among the most successful fund investment fields, there are Software, Consumer Software. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
Related Funds
| Fund Name | Location |
| b10 | Venture Capital | Berlin, Berlin, Germany |
| Global Catalyst Partners Japan | Chiyoda, Japan |
| HOPU-Arm Innovation Fund | - |
| Marshfield Clinic | Marshfield, United States, Wisconsin |
| Newid capital | Alexandria, United States, Virginia |
| Smith+Crown | Oregon, Portland, United States |
| sopoong | Seoul, Seoul-t'ukpyolsi, South Korea |
| STV | Ar Riyad, Riyadh, Saudi Arabia |
| Unreal Engine | Cary, North Carolina, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Alto Pharmacy | $50M | 05 Dec 2018 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Alto Pharmacy | $50M | 05 Dec 2018 | San Francisco, California, United States |
